Oncologic Outcomes of Renal Cell Carcinoma Patients Undergoing Radical Nephrectomy and Venous Thrombectomy: Prospective Follow-Up from a Single Center
Table 3
Overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) of the study cohort.
OS
CSS
RFS ()
Median mon, (95% CI)
1 yr
3 yr
5 yr
1 yr
3 yr
Median mon, (95% CI)
1 yr
3 yr
All
56.0 (47.6-64.3)
87.0%
62.1%
44.8%
89.3%
72.7%
—
—
—
Distant metastasis
M1
27.0 (22.0-42.0)
78.0%
41.5%
23.3%
83.2%
55.6%
—
—
—
M0
89.4%
68.6%
55.3%
90.0%
75.3%
38.0 (32.5-43.5)
81.2%
52.3%
N0-xM0
88.3%
66.2%
51%
89.7%
78.6%
40.7 (34.6-47.4)
84.4%
56.9%
N1M0
89.3%
72.6%
91.5%
74.2%
33.2 (28.2-37.7)
70.6%
51.3%
Thrombus level
I
90.5%
78.1%
—
91.5%
78.5%
38.7 (33.6-54.4)
84.7%
80.4%
II
42.0 (34.9-49.1)
87.3%
58.5%
—
89.9%
65.9%
30.9 (28.8-37.1)
85.8%
56.0%
III
40.0 (26.3-44.1)
81.5%
57.9%
36.4%
83.8%
71.6%
23.3 (18.8-37.2)
68.7%
35.4%
OS: overall survival; CSS: cancer-specific survival; RFS: recurrence-free survival; mon: month; CI: confidence interval; the median survival was not reached.
